https://de.marketscreener.com/kurs/aktie/DAIICHI-SANKYO-CO-LTD-6498062/news/Daiichi-Sankyo-und-Merck-geben-bekannt-dass-der-erste-Patient-in-der-Phase-2-3-Studie-Rejoice-Ovari-46349973/?utm_source=telegram&utm_medium=social&utm_campaign=share